Filing Details
- Accession Number:
- 0000950170-24-084186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-17 14:52:30
- Reporting Period:
- 2024-07-15
- Accepted Time:
- 2024-07-17 14:52:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1783183 | Phathom Pharmaceuticals Inc. | PHAT | Pharmaceutical Preparations (2834) | 824151574 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1791412 | Azmi Nabulsi | C/O Phathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 Florham Pak NJ 07932 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-07-15 | 10,901 | $11.72 | 240,421 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,579 | Indirect | By 401(k) |
| Common Stock | 785,700 | Indirect | By Trust |
Footnotes
- Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan
Billionaire Hedge Funds
